Introduction

While most people recover from COVID-19 within weeks, a growing number continue to face lingering health challenges. This condition, widely known as Long COVID or Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), can last for months or even years. According to the World Health Organization (WHO), up to 10–20% of patients infected with COVID-19 experience ongoing symptoms that disrupt daily life.

Common manifestations of Long COVID include:

Chronic fatigue and extreme tiredness that does not improve with rest
“Brain fog” with poor concentration, memory lapses, and slowed thinking
Shortness of breath and persistent cough
Chest pain and palpitations
Muscle and joint pain
Sleep disturbances, depression, and anxiety
Worsening of pre-existing chronic conditions, such as diabetes or hypertension

What makes Long COVID so challenging is its complexity. The virus does not simply cause one type of damage; instead, it appears to trigger a cascade of immune dysregulation, inflammation, vascular injury, and nervous system disruption. Standard treatment today remains largely symptomatic—using medications to manage fatigue, breathing difficulties, or pain—but does not fully address the root causes.

This growing gap between need and available care is pushing patients and medical researchers to explore regenerative medicine solutions. One of the most promising approaches is personalized stem cell therapy.

Why Stem Cells?

Stem cells, particularly mesenchymal stem cells (MSCs), have gained attention for their unique healing potential. Unlike traditional medications that target one pathway, stem cells act as multi-functional repair agents.

Key benefits of MSC therapy include:

Immune System Modulation
- Long COVID is often driven by an overactive or “stuck” immune response. MSCs release bioactive molecules that can calm harmful inflammation while supporting protective immunity. This balance helps reduce chronic fatigue, pain, and autoimmune-like symptoms.
Tissue Repair and Regeneration
- Stem cells encourage the body to regenerate damaged lung tissue, nerve cells, and blood vessels. For patients with breathing difficulties or neurological symptoms, this regenerative capacity can be life-changing.
Anti-Fibrotic Effects
- Persistent inflammation after COVID-19 can lead to fibrosis (scarring), especially in the lungs. MSCs have shown the ability to reduce fibrotic changes, preserving organ function.
Enhanced Vascular Function
- Many Long COVID symptoms are linked to microvascular injury—tiny blood clots and vessel inflammation that limit oxygen delivery to tissues. MSCs promote healthier circulation by stimulating new blood vessel formation and reducing clotting risks.

Recent clinical evidence is encouraging. A 2025 follow-up study published in Stem Cell Research & Therapy found that patients who received MSC therapy after severe COVID-19 experienced sustained improvements in lung function, reduced fatigue, and better quality of life over a three-year period. Importantly, the treatment was shown to be safe and well-tolerated, even in patients with pre-existing conditions.

Personalized Therapy at Dekabi Stem Cell Clinic

At Dekabi Stem Cell Clinic in Seoul’s Gangnam district, stem cell therapy is not applied as a one-size-fits-all procedure. Under the leadership of Dr. Eun Young Baek, with more than 22 years of stem cell expertise and over 34 years in the medical field, the clinic has developed a personalized, patient-centered approach that sets it apart.

For Long COVID patients, the clinic offers a structured, tailored treatment program that may include:

1:1 Stem Cell Therapy Plans
Every patient’s immune profile, medical history, and symptom severity are carefully evaluated. Treatments are then customized to optimize safety and maximize effectiveness.
Energy & Functional Medicine Integration
Long COVID is not only about physical damage but also about energy depletion and systemic imbalance. Dekabi incorporates energy surgery, detoxification methods, and functional neurology support to restore vitality and resilience.
Anti-Aging and Chronic Disease Management
Many Long COVID patients also struggle with conditions such as diabetes, cardiovascular disease, or accelerated aging due to chronic inflammation. Dekabi’s integrated approach ensures that these underlying issues are addressed alongside COVID-related symptoms.

This holistic strategy allows patients to benefit not just from advanced regenerative techniques, but also from comprehensive medical support that targets both the cause and the consequence of Long COVID.

Safety and Progress in Global Research

When exploring new therapies, safety is always the top priority. Fortunately, stem cell research has made significant strides in recent years.

Global Trials: Clinical studies in Europe, Asia, and the United States are actively testing MSCs for COVID-19 and Long COVID. Early-phase results consistently show reductions in inflammation, fatigue, and breathlessness.
Regulatory Approvals in Related Fields: Stem cell therapy has already gained FDA approval for other immune-related conditions, such as graft-versus-host disease (GVHD). This track record strengthens the case for safety and reliability when applied to Long COVID.
Long-Term Monitoring: Recent longitudinal studies demonstrate that stem cell therapy is not only safe but provides sustained benefits for years after treatment.

It is important for patients to understand that while research is ongoing, the field of regenerative medicine is rapidly moving from experimental to evidence-based care. Clinics like Dekabi, with decades of experience, are at the forefront of this transition.

Patient Stories and Real-World Impact

Although scientific data is vital, the most compelling evidence often comes from patient experiences. Around the world, Long COVID patients who have undergone MSC therapy report:

Noticeable increases in energy levels
Clearer cognitive function, with reduced brain fog
Improved breathing capacity and endurance
Relief from chronic pain and inflammation
A return to everyday activities that once felt impossible

At Dekabi, patients not only receive medical treatment but also compassionate care that acknowledges the emotional and psychological burden of Long COVID. This patient-first philosophy is central to the clinic’s reputation as a trusted leader in regenerative medicine.

A New Horizon for Patients

For millions worldwide, Long COVID has become a frustrating and sometimes debilitating condition. Traditional medical systems often focus on symptom control, leaving many patients searching for more comprehensive solutions.

Personalized stem cell therapy offers a new horizon of hope. By targeting the underlying immune dysfunction and tissue damage, MSCs provide a pathway not just for symptom relief but for true biological recovery.

At Dekabi Stem Cell Clinic, patients gain access to:

Over two decades of pioneering expertise in stem cell applications
A proven track record in pain management, chronic disease treatment, and anti-aging medicine
A personalized and holistic treatment approach that values each patient’s unique journey

Long COVID does not have to be a life sentence. With regenerative medicine advancing rapidly, patients now have the opportunity to explore therapies that restore both health and vitality.

Final Thoughts

Long COVID remains one of the greatest medical challenges of our time, but innovation is transforming the outlook. Stem cell therapy—especially when personalized to each patient—holds the potential to turn lingering illness into lasting recovery.

At Dekabi Stem Cell Clinic, our mission is to deliver cutting-edge, compassionate care that empowers patients to reclaim their lives. For those suffering from Long COVID, this represents not just treatment, but a new beginning.